Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial

Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial

Journal Pre-proof Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial Nickolas C...

1MB Sizes 0 Downloads 40 Views

Journal Pre-proof Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial Nickolas C. Teigen, MD, Nicole Sahasrabudhe, MD, Georgios Doulaveris, MD, Xianhong Xie, PhD, Abdissa Negassa, PhD, Jeffrey Bernstein, MD, Peter S. Bernstein, MD, MPH PII:

S0002-9378(19)31234-7

DOI:

https://doi.org/10.1016/j.ajog.2019.10.009

Reference:

YMOB 12926

To appear in:

American Journal of Obstetrics and Gynecology

Received Date: 16 July 2019 Revised Date:

1 October 2019

Accepted Date: 16 October 2019

Please cite this article as: Teigen NC, Sahasrabudhe N, Doulaveris G, Xie X, Negassa A, Bernstein J, Bernstein PS, Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay: A Randomized Controlled Trial, American Journal of Obstetrics and Gynecology (2019), doi: https://doi.org/10.1016/j.ajog.2019.10.009. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Elsevier Inc. All rights reserved.

1

Enhanced Recovery after Surgery (ERAS) at Cesarean to Reduce Postoperative Length of Stay:

2

A Randomized Controlled Trial

3 4

Nickolas C. Teigen MD1

5

Nicole Sahasrabudhe MD2

6

Georgios Doulaveris MD3,

7

Xianhong Xie PhD4,

8

Abdissa Negassa PhD4,

9

Jeffrey Bernstein MD5,

10

Peter S. Bernstein MD, MPH3

11 12 13

(1) Georgia Perinatal Consultants. Atlanta, GA 30342

14

(2) Kaiser Permanente Southern California, Department of Obstetrics & Gynecology, Downey,

15

CA 90242

16

(3) Albert Einstein College of Medicine / Montefiore Medical Center, Department of Obstetrics

17

& Gynecology and Women's Health, Bronx, NY 10461

18

(4) Albert Einstein College of Medicine / Montefiore Medical Center, Department of

19

Epidemiology and Population Health, Bronx, NY 10461

20

(5) New York University, Department of Anesthesia, New York, NY 10016

21 22

Disclosure: The authors report no conflict of interest. This study received no financial support.

23

CONDENSATION

24

Enhanced recovery after surgery at cesarean did not increase the rate of discharge on

25

postoperative day #2, but did result in improved rates of breastfeeding.

26 27

SHORT TITLE

28

Enhanced Recovery after Surgery (ERAS) at cesarean delivery

29 30

AJOG AT A GLANCE

31

A. Why was this study conducted?

32

To compare whether an enhanced recovery after surgery (ERAS) pathway at cesarean would

33

increase the rate of early hospital discharges and improve postoperative patient satisfaction

34

compared to standard perioperative care.

35

B. What are the key findings?

36

Enhanced Recovery after Surgery (ERAS) at cesarean was not associated with an increase in the

37

number of women discharged early. Evidence that ERAS after cesarean may have the potential

38

to improve outcomes such as day of discharge are suggested by the observed reduction in

39

overall postoperative length of stay, improved patient satisfaction and an increase in

40

breastfeeding rates.

41

C. What does this study add to what is already known?

42

This prospective randomized trial adds to the paucity of literature on ERAS at Cesarean and

43

reaffirms the potential benefits of ERAS at Cesarean to improve postoperative outcomes

44

including overall postoperative length of stay and exclusive breastfeeding rates.

45

ClinicalTrials.gov Identifier: NCT02956616.

46

Date of registration 11/7/2016

47

Date of initial participant enrollment 9/1/2017

48

https://clinicaltrials.gov/ct2/show/NCT02956616?cond=enhanced+recovery+cesarean&rank=1

49 50

Poster presented at the SMFM 39th Annual Meeting, Las Vegas, Nevada. February 11 –

51

February 16, 2019. Final program ID number 977.

52 53

Corresponding author:

54

Nickolas Teigen, MD

55

1000 Johnson Ferry Road NE

56

Atlanta, GA 30342

57

Email: [email protected]

58

617-835-1032

59 60

Word count:

61

Abstract: 348

62

Main text: 2734

63

64

ABSTRACT

65

OBJECTIVE:

66

Our objective was to determine whether an enhanced recovery after surgery (ERAS) pathway at

67

the time of cesarean birth would permit a reduction in postoperative length of stay and

68

improve postoperative patient satisfaction compared to standard perioperative care (SC).

69 70

STUDY DESIGN:

71

Patients undergoing nonemergent cesarean delivery at ≥ 37 weeks of gestation were

72

randomized to ERAS or SC. ERAS involved multiple evidence-based interventions bundled into

73

one protocol. The primary outcome was discharge on postoperative day 2 (POD#2). Secondary

74

outcome variables included pain medication requirements, breastfeeding rates and various

75

measures of patient satisfaction.

76 77

RESULTS:

78

From September 27, 2017 to May 2, 2018, 58 women were randomized to ERAS and 60 to SC.

79

The groups were similar in medical comorbidities, demographic and perioperative

80

characteristics. ERAS was not associated with a significantly increased rate of POD#2 discharges

81

when compared with SC, 8.6% vs. 3.3%, respectively (OR: 2.74, 95% CI 0.51-14.70), but it was

82

associated with a significantly reduced postoperative length of stay (LOS) when compared with

83

standard care, with median LOS of 73.5 [(IQR): 71.08-76.62)] v. 75.5 [(IQR: 72.86-76.84)] hours

84

from surgery, difference in median LOS: (-1.92, 95% CI -3.80 - -0.29). ERAS was not associated

85

with a reduction in postoperative narcotic use, 117.16 ± 54.17 vs. 119.38 ± 47.98 morphine

86

milligram equivalents (Mean difference: -2.22, 95% CI -20.86-16.42). More subjects randomized

87

to the ERAS protocol reported breastfeeding at discharge, 67.2% vs. 48.3% (p=0.046). When

88

patients were surveyed 6 weeks postpartum, those in the ERAS group were more likely to feel

89

that their expectations were met, they achieved their postoperative milestones earlier and to

90

report continued breastfeeding.

91 92

CONCLUSION:

93

ERAS after cesarean was not associated with an increase in the number of women discharged

94

on POD#2, but that may have been related to factors other than patients’ medical readiness for

95

discharge. Evidence that ERAS after cesarean may have the potential to improve outcomes such

96

as day of discharge are suggested by the observed reduction in overall postoperative LOS,

97

improved patient satisfaction and an increase in breastfeeding rates. Even better results may

98

accrue with more provider and patient experience with ERAS.

99

BACKGROUND:

100

Enhanced recovery after surgery (ERAS) involves changes to multiple aspects of perioperative

101

care with the aim of standardizing postoperative patient care, improving patient outcomes,

102

reducing postoperative length of stay, and optimizing patient satisfaction.1 Enhanced recovery

103

pathways have been widely implemented in many different areas of surgery. Initially, these

104

pathways were introduced in colorectal surgery nearly 15 years ago, but have found more

105

widespread usage in surgical specialties including urology, orthopedics, breast surgery and

106

gynecologic surgery. Initiation of enhanced recovery programs have consistently resulted in

107

reduced hospital length of stay, financial savings and improved patient satisfaction.2

108 109

To date, only observational and retrospective studies have been performed looking at the

110

introduction of enhanced recovery pathways at cesarean. In one observational study, the

111

investigators were able to successfully introduce an enhanced recovery program to their

112

obstetrics unit and noted a greater proportion of patients discharged earlier with improved

113

patient satisfaction, without a concomitant increase in readmission rates.3 A recent

114

retrospective study showed that Implementation of an ERAS program for women

115

having planned or unplanned CD was associated with significantly decreased postoperative

116

length of stay (4.86 hours) and significant cost-savings per patient, without increase in hospital

117

readmissions.4

118 119

The components of enhanced recovery pathways vary significantly, though all seek to provide

120

benefits to patients by optimizing the postoperative recovery course through the combination

121

of multiple evidence-based components 5-7. In a previous study aimed at post-cesarean birth

122

discharge timing, comparing early versus usual discharge time, there was no difference

123

observed in the number of maternal readmissions, maternal antibiotic use, maternal well-being

124

and anxiety or depression.8

125 126

Components of enhanced recovery pathways can include standardization of the use of

127

prophylactic antibiotics, venous thromboembolism prophylaxis, minimizing starvation times,

128

use of antiemetics, earlier resumption of feeding postoperatively, use of chewing gum

129

postoperatively, early removal of dressings and urinary catheters, and standing postoperative

130

pain medication orders.9

131 132

Currently, no randomized studies exist in the literature specifically addressing the potential

133

impact of an enhanced recovery pathway among women undergoing cesarean births on

134

postoperative outcomes and postoperative length of stay. Enhanced Recovery after Surgery

135

after cesarean is not practiced at our institution and is not practiced nationally in a consistent

136

fashion.

137 138

Our objective was to determine whether an enhanced recovery after surgery (ERAS) pathway at

139

the time of cesarean birth would permit a reduction in postoperative length of stay and

140

improve postoperative patient satisfaction compared to standard perioperative care (SC).

141 142

METHODS:

143

This was a prospective, randomized clinical trial enrolling pregnant women at the Jack D. Weiler

144

Hospital of Montefiore Medical Center (Bronx, NY) in an urban, academic hospital setting. The

145

study protocol was approved by the institutional review board and written informed consent

146

was obtained from all women prior to enrollment. Women were eligible for enrollment if they

147

had a gestational age of 37 0/7 completed weeks or greater based on the best obstetric

148

estimated due date and were undergoing a scheduled or non-emergent cesarean delivery. Best

149

obstetric estimated due date was used to establish the subject’s due date: either last menstrual

150

period or ultrasound if the last menstrual period was unknown or if a discrepancy with last

151

menstrual period was noted as per American College of Obstetricians and Gynecologists

152

guidelines. Patients were excluded if they were less than 37 weeks of gestation, undergoing an

153

emergent cesarean birth, receiving general anesthesia or had a pregnancy complicated by an

154

active infection, morbidly adherent placenta, pre-existing hypertension or pregnancy induced

155

hypertension preoperatively which would potentially prolong their hospitalization. Patients

156

were also excluded if they had any renal impairment, peptic ulcer disease or known

157

hypersensitivity to ketorolac, all reasons for which they would not be able to receive ketorolac.

158 159

Participants were enrolled by one of the authors on the day of cesarean delivery and after

160

obtaining informed consent were randomized to either an enhanced recovery after surgery

161

(ERAS) protocol for their perioperative care or standard perioperative recovery. Randomization

162

was computer-generated before the first patient was enrolled utilizing Randomization.com with

163

block sizes of four. The randomization allocation was concealed in opaque, identical,

164

sequentially numbered, sealed envelopes. The numbered envelope was opened after written

165

consent was obtained and before the patient entered the operating room. Preoperative

166

surgical preparation and antibiotic prophylaxis followed standard institutional protocols. All

167

women received neuraxial analgesia: spinal, epidural, or combined spinal and epidural.

168

Cesarean delivery techniques followed the preference of the attending surgeon. Following the

169

completion of surgery, computerized postoperative order sets were placed for each patient

170

based on the study arm to which they were previously assigned (Figure 1). Postoperative

171

recovery followed the usual service protocols including ambulation at the patient's discretion,

172

diet initiation at the patient's discretion, urinary catheter removal on postoperative day #1,

173

postoperative dressing removal on postoperative day #1 and ketorolac and narcotic pain

174

medication as needed for pain. Alternatively, the components of the enhanced recovery

175

protocol included several evidence-based recommendations: early ambulation, early diet

176

initiation, early removal of urinary catheter, early removal of postoperative dressing and

177

standing ketorolac for 24 hours postoperatively (Table 1).

178 179

Demographic features, medical comorbidities, and known perioperative risk factors for

180

postoperative complications were recorded. The primary outcome was discharge on

181

postoperative day #2 and was determined by review of the post-cesarean medical record. The

182

discharging provider was not aware of the group allocation. Only the provider who performed

183

the cesarean was aware of the group allocation as they placed the postoperative orders upon

184

completion of the surgery. Discharge timing of the women in our study was based on provider

185

and patient expectations and not based on medical eligibility for discharge. Postoperative Day

186

#2 was selected as the primary outcome as the day of discharge after cesarean in our

187

institution has traditionally been postoperative day #3. Secondary outcomes assessed were

188

postoperative pain medication use, postoperative complications (wound complications, urinary

189

infections, postpartum depression, hospital readmission), breastfeeding initiation determined

190

from the medical record and postoperative telephone survey and breastfeeding continuation

191

determined from postoperative telephone survey. Patient satisfaction and outcome

192

information was determined by telephone contact six weeks after the procedure with a

193

telephone interview and survey.

194 195

To detect a reduction of the primary outcome on early hospital discharges on postoperative day

196

#2 at a rate decrease of 20% with power of 0.80 and a two-tailed alpha of 0.05, 59 women per

197

study group were required for a total of 118 in the study. We assumed a baseline rate of early

198

hospital discharges of 10% in our institution based upon a pilot of implementing early hospital

199

discharges and querying obstetrical providers regarding our institution's practice.

200 201

Postoperative telephone surveys were conducted 6 weeks postpartum to assess patient

202

satisfaction and postoperative experience and complications. Women were asked a series of

203

multiple-choice questions using a Likert scale.

204 205

Demographic characteristics, medical comorbidities and perioperative information were

206

described by study group as mean (SD) or median (range) for continuous variables and

207

frequency (%) for categorical variables as appropriate. Differences between study arms were

208

assessed using t-test or nonparametric equivalent for continuous variables and Pearson chi-

209

square or Fisher exact test for categorical variables as appropriate. Odds ratio (with 95% CI) was

210

used to assess and quantify effect on postoperative complications. Analysis was based on

211

intention to treat principle. All p values were two-sided and a p value ≤ 0.05 was deemed

212

statistically significant. Statistical analysis was performed using STATA (College Station, TX). The

213

study was registered with ClinicalTrials.gov, NCT02956616.

214 215

RESULTS:

216

From September 27, 2017, to May 2, 2018, two hundred twenty-three women were assessed

217

for inclusion, 33 women were excluded as they met one or more exclusion criteria, 69 women

218

declined participation in the study, leaving 121 women that were randomized. Of those

219

randomized, there were 3 protocol breaches assigned to the incorrect study arm, resulting in 58

220

women randomized to enhanced recovery after surgery and 60 women randomized to standard

221

perioperative care (Figure 1). Randomization resulted in groups that were similar in

222

demographic characteristics, medical comorbidities and perioperative characteristics (Table 2).

223 224

Enhanced recovery after surgery at cesarean was not associated with a significantly increased

225

rate of early hospital discharges on postoperative day #2 when compared with standard

226

recovery, 8.6% vs. 3.3% (Effect estimate 2.74, 95% CI 0.51-14.70, p=0.24). We did observe a

227

significantly reduced postoperative length of stay in the enhanced recovery protocol group

228

when compared with standard perioperative care group, 73.5 hours (71.1-76.6) compared with

229

75.5 hours (72.8-76.8), Effect estimate -1.92, p=0.046. No differences were noted in

230

postoperative narcotic requirement, 117.16 ± SD 54.17 vs. 119.38 ± SD 47.98 morphine

231

milligram equivalents (Effect estimate -2.22, 95% CI -20.86-16.42, P=0.81).

232 233

Enhanced recovery after surgery at cesarean was associated with an increase in exclusive

234

breastfeeding postoperatively, with 67.2% exclusively breastfeeding in the enhanced recovery

235

arm compared to 48.3% in the standard recovery group, p=0.046. There were no differences in

236

breastfeeding protocols between the study arms.

237 238

There were no statistically significant differences between the groups when comparing

239

postoperative complications including postoperative infections, gastrointestinal complications,

240

genitourinary complications, wound complications, bleeding complications, hospital

241

readmissions, hypertensive disorder complications or postpartum depression (Table 3).

242 243

Postoperative telephone surveys were conducted at 6 weeks postpartum to assess patient

244

satisfaction and postoperative experience and complications. Women in the Enhanced

245

Recovery arm were more likely to feel that their recovery met expectations, more satisfied with

246

postoperative dietary allowances, more satisfied with their ability to ambulate and more

247

satisfied with their ability to breastfeed. There were however no differences in their perception

248

of preoperative education, postoperative pain control or their perceived ability to bond with

249

their infants (Table 4).

250 251

STRUCTURED DISCUSSION:

252

Principal findings of the study

253

Enhanced recovery after surgery at cesarean was not associated with an increased rate of early

254

hospital discharges on postoperative day #2 compared with standard perioperative care.

255

However, enhanced recovery after surgery at cesarean was associated with a reduction in

256

overall postoperative length of stay compared with standard perioperative care (73.5 hours vs.

257

75.5 hours). Notably, enhanced recovery after surgery at cesarean was also associated with an

258

increase in the percent of women that exclusively breastfed their infants in the postpartum

259

period.

260 261

RESULTS:

262

Although our primary outcome measure did not show an increased rate of early hospital

263

discharges, this is in direct contrast to an enhanced recovery protocol in colorectal surgery

264

which permitted earlier hospital discharges and improved patient satisfaction.10 Adequate

265

comparisons of benefits of enhanced recovery versus standard recovery after cesarean delivery

266

are lacking. An observational study from the United Kingdom was able to successfully introduce

267

an enhanced recovery program to their obstetrics unit and noted a greater proportion of

268

patients discharged earlier, 1.6% on postoperative Day 1 vs. 25.2% on postoperative day 2.11

269

Implementation of this program occurred over the span of 2 years without a concomitant

270

increase in hospital readmissions. Additionally, a retrospective cohort study evaluating

271

implementation of an ERAS pathway for women having cesarean deliveries was associated with

272

decreased postoperative length of stay and cost savings.12

273

However, no prospective randomized trials have been conducted specifically addressing the

274

impact of an enhanced recovery after surgery program on postoperative day of discharge and

275

other postoperative outcomes.

276 277

Clinical Implications

278

Enhanced recovery after surgery at cesarean may have many novel clinical benefits including

279

reducing postoperative length of stay, improving patient satisfaction and increasing the rate of

280

exclusive breastfeeding and reducing postoperative narcotic usage. These interventions may

281

potentially reduce healthcare costs and decrease utilization of hospital resources.

282 283

The specific effect of enhanced recovery on exclusive breastfeeding is unclear. There may be

284

components of enhanced recovery such as encouragement of early ambulation, early feeding

285

and early resumption of normal activity that may help new mothers to feel well after their

286

surgery and more able to exclusively breastfeed their newborns. Specifically addressing this

287

effect of enhanced recovery on breastfeeding may have clinical utility in improving

288

breastfeeding rates in the postpartum period.

289 290

Enhanced recovery after surgery at cesarean was not associated with a reduction in

291

postoperative narcotic usage. We speculate that the lack of reduction in postoperative narcotic

292

use may be multifactorial. Administration of narcotics in the postoperative period can be

293

impacted by the underlying culture within the institution of providing postoperative pain

294

control based on the provider's perception of the patient's need for narcotics and not based on

295

a true objective measure of a patient's narcotic need based on pain scores. Patients in the

296

enhanced recovery arm received ketorolac 15mg intravenously every 6 hours for 24 hours (60

297

mg in total) in comparison to ketorolac administered on an as needed basis in the standard

298

recovery arm. In the control group, patients received a median of 30 (0-60) grams versus 60

299

(60-60) grams (p< 0.001). The significant variability in the administration of ketorolac in the

300

standard recovery arm may reflect that patients and staff were opting to manage postoperative

301

pain without turning to narcotics, and thus mitigating any reduction in postoperative narcotic

302

requirements.

303 304

Research Implications

305

The inability of our study to show a significant difference in the primary outcome measure may

306

be due to limitations of using postoperative day of discharge as a primary outcome measure of

307

medical stability of discharge in our study population. Determination of timing of a patient's

308

medical eligibility for discharge may be confounded by factors such as prolonged neonatal

309

observation in the postpartum period and sociodemographic factors that may preclude early

310

hospital discharge when a woman is deemed medically stable for discharge. Furthermore,

311

discharge timing may be based on patient and provider preferences, expectations, and habits

312

and not based on medical eligibility criteria alone. To show if the difference that we observed in

313

our primary outcome was statistically significant, we performed a post hoc analysis and found

314

that 309 subjects per group would be needed for such a study. Further investigation that

315

includes more in-depth perioperative education materials and a larger study based on our

316

findings including an economic analysis is warranted.

317 318

Strengths and Limitations

319

The main strength of our study was the prospective, randomized study design. The structure of

320

our intervention, however, was not without limitations. Key to an enhanced recovery protocol

321

is perioperative patient education. The perioperative education that was provided in our study

322

related to enhanced recovery was limited to when informed consent was obtained for

323

participation in the study, which was completed just prior to surgery. Given our institutions

324

multiple offices and non-centralized presurgical process, we felt that the only way to achieve

325

standardized education and informed consent was to perform this at the site of where the

326

procedure was occuring, and this was only possible on the day of the procedure. A more

327

thorough perioperative education component may be beneficial at better establishing patient

328

and provider expectations for discharge. In addition, the discharge timing of the women in our

329

study was based on provider and patient expectations and preferences and often not on their

330

medical eligibility. We anticipated 10% of the patients in our standard recovery arm would opt

331

for discharge on postoperative day #2 but actually found that only 3.3% did. It was not possible

332

to determine from the medical record reasons why patients were not discharged on

333

postoperative day #2. An additional limitation of our study was that it was not blinded;

334

performing a blinded study would be difficult to do with this sort of intervention. The majority

335

of the procedures were scheduled and performed during the morning or early afternoon hours

336

(115/118) and therefore we did not anticipate that the time of day that the procedure was

337

performed would have an impact on the primary outcome measure. An additional limitation of

338

our study was that 102 of the eligible 223 subjects were not included in our study because they

339

declined participation. This large rate of declining participation could introduce bias, but that

340

should have been mitigated by the fact that randomization occurred after patients agreed to

341

participate. We do not anticipate that the cesarean delivery technique would add bias because

342

the patients were randomized. An additional limitation of our study is that there may have

343

been cross-over with some patients receiving interventions from the enhanced recovery order

344

set that nursing found potentially beneficial for their patient. Finally, the generalizability of our

345

study may be limited since it was performed at a single center.

346 347

Conclusions

348

In conclusion, we were unable to show an increase in our primary outcome measure of early

349

hospital discharges on postoperative day #2 when patients underwent enhanced recovery after

350

surgery after cesarean in comparison to standard recovery. However, our study was able to

351

show a significant reduction in total postoperative length of stay as well as a significant increase

352

in exclusive breastfeeding with enhanced recovery after surgery which is a novel finding.

353

REFERENCES:

354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395

1. Wilson R, Caughey A, Wood S, Macones G, Wrench I, Huang J, Norman M, Petersson K, Fawcett W, Shalabi M, Metcalfe A, Gramlich L, Nelson G. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations. American Journal of Obstetrics & Gynecology. 2018 Dec;219(6):523-544. 2. Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011 Jun;149(6):830-840. 3. Wrench, IJ, Allison, A, Galimberti, A, Radley, S, Wilson, MJ. Introduction of enhanced recovery for elective caesarean section enabling next day discharge: a tertiary centre experience. Int J Obstet Anesth. 2015. 24, 2: 124-130. 4. Fay E, Bollag L, Delgado C, Savitsky L, Mills E, Slater J, Hitti J. An enhanced recovery after surgery pathway for cesarean delivery decreases hospital stay and cost. American Journal of Obstetrics & Gynecology. JANUARY 2019. S142 5. Wilson, R. Douglas et al. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations (Part 1) American Journal of Obstetrics & Gynecology, Volume 219, Issue 6, 523.e1 - 523.e15 6. Caughey, Aaron B. et al. Guidelines for intraoperative care in cesarean delivery: Enhanced Recovery After Surgery Society Recommendations (Part 2). American Journal of Obstetrics & Gynecology, Volume 219, Issue 6, 533 - 544 7. Macones, George A. et al.Guidelines for postoperative care in cesarean delivery: Enhanced Recovery After Surgery (ERAS) Society recommendations (part 3)American Journal of Obstetrics & Gynecology, Volume 219 8. Brooten D, Roncoli M, Finkler S, Arnold L, Cohen A., Mennuti M. A randomized trial of early hospital discharge and home follow-up of women having cesarean birth. Obstet Gynecol, 1994. 84: 832-838. 9. Wilson R, Caughey A, Wood S, Macones G, Wrench I, Huang J, Norman M, Petersson K, Fawcett W, Shalabi M, Metcalfe A, Gramlich L, Nelson G. Guidelines for Antenatal and Preoperative care in Cesarean Delivery: Enhanced Recovery After Surgery Society Recommendations. American Journal of Obstetrics & Gynecology. 2018 Dec;219(6):523-544. 10. Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011 Jun;149(6):830-840.

396 397 398 399 400 401

11. Wrench, IJ, Allison, A, Galimberti, A, Radley, S, Wilson, MJ. Introduction of enhanced recovery for elective caesarean section enabling next day discharge: a tertiary centre experience. Int J Obstet Anesth. 2015. 24, 2: 124-130. 12. Fay, Emily E.Hitti, Jane E.Delgado, Carlos M.Savitsky, Leah M.Mills, Elizabeth B.Slater, JoAnn L.Bollag, Laurent A. et al. American Journal of Obstetrics & Gynecology, 2019.

Figure 1. Algorithm of Randomization

Assessed for eligibility (n=223) Excluded (n=33) Declined (n=69) Randomized (n=121)

Enhanced Recovery

Standard

(n=58)

(n=60) Protocol Deviations (n=3)

Completed Follow-up Survey

Completed Follow-up Survey

(n=56)

(n=53)

Table 1. Enhanced Recovery After Surgery (ERAS) Protocol Chewing gum (Xylitol) to reduce postoperative Ileus Intravenous NSAIDS (Ketorolac) for 24 hours postoperatively to reduce postoperative narcotic use Early initiation of feeding after cesarean: Clear liquid diet immediately in the PACU, Regular diet at 30 minutes Early removal of urinary catheter at 12 hours Early removal of dressing at 6 hours Early mobilization at 12 hours Incentive Spirometry encouraged every 8 hours

Table 2. Patient Demographics, Perioperative Information, and Medical Comorbidities Characteristic

Enhanced Recovery

Standard Recovery

(n=58)

(n=60)

Age (years), mean ± SD

30.43 ± 4.92

31.93 ± 5.43

0.12

BMI (kg/m2), mean ± SD

34.79 ± 6.78

33.34 ± 6.09

0.22

Ethnicity, n (%)

p-value

0.77

Caucasian

4 (6.9)

4 (6.7)

African American

13 (22.4)

16 (26.7)

Hispanic

33 (56.9)

29 (48.3)

Asian

3 (5.2)

2 (3.3)

Other

5 (8.6)

9 (15.0)

Gestational Age (weeks), Median (IQR)

39.0 (39.0-39.3)

39.1 (39.0-39.4)

0.62

Multiparous, n (%)

48 (88.9)

48 (85.7)

0.62

Prior Cesarean Delivery, Median (IQR)

1 (1-2)

1 (1-2)

0.88

Indication for Cesarean Delivery, n (%)

0.66

Prior Cesarean Delivery

50 (86.2)

46 (76.7)

Malpresentation

4 (6.9)

6 (10.0)

Suspected Macrosomia

2 (3.5)

6 (6.7)

Prior Myomectomy

0 (0)

1 (1.7)

Active HSV

0 (0)

1 (1.7)

Twin Gestation

2 (3.5)

1 (1.7)

Primary Elective

0 (0)

1 (1.7)

Estimated Blood Loss (mL), Median (IQR)

800 (700-1000)

800 (800-1000)

0.79

Estimated Blood Loss 1000 mL or greater, n (%)

19 (32.8)

21 (35.0)

0.80

Skin Closure, n (%)

1.00

Monocryl

55 (94.8)

55 (91.7)

Vicryl

0 (0)

1 (1.7)

Staples

3 (5.2)

1 (6.7)

35.34 ± 3.32

35.52 ± 2.97

Preoperative HCT, mean ± SD

0.75

Postoperative Day 1 HCT, mean ± SD

30.52 ± 3.42

30.89 ± 3.31

0.55

Chronic Hypertension, n (%)

0 (0)

0 (0)

NA

Diabetes Mellitus, n (%)

6 (10.3)

12 (20.0)

0.14

Hypertensive Disorder of Pregnancy, n (%)

4 (6.9)

6 (10.0)

0.74

Birthweight, mean ± SD

3409.97 ± 422.74

3348.12 ± 487.69

0.46

Apgar >7 at 5 min, n (%)

55 (94.8)

57 (95.0)

1.00

NICU Admission, n (%)

2 (3.5)

2 (3.3)

1.00

Table 3. Study Outcomes Outcome

Enhanced

Standard

Effect Estimate (95% CI)

p-value

Recovery

Recovery

5 (8.6)

2 (3.3)

2.74 (0.51, 14.70)

0.24

Postoperative length of hospital stay (Hours),

73.58 (71.08-

75.50 (72.86-

-1.92 (-3.80,

0.046

Median (IQR)

76.62)

76.84)

-0.29)

Postoperative Narcotic Use (MME), Mean ± SD

117.16 ± 54.17

119.38 ± 47.98

-2.22 (-20.86, 16.42)

Primary Outcome Discharge on POD#2, n (%) Secondary Outcomes

Breastfeeding, n (%)

0.81 0.046

Breastfeeding

39 (67.2)

29 (48.3)

Bottle

4 (6.9)

2 (3.3)

Both

15 (25.9)

29 (48.3)

Postoperative infection, n (%)

0 (0)

2 (3.3)

0.20 (0.00, 2.53)

0.31

Gastrointestinal Complication, n (%)

1 (1.7)

7 (11.7)

0.13 (0.02, 1.12)

0.06

Wound Complication, n (%)

0 (0)

4(6.7)

0.11 (0.00, 1.04)

0.14

Bleeding Complication, n (%)

19 (32.8)

20 (33.3)

0.97 (0.45, 2.10)

0.95

Postpartum Depression, n (%)

4 (6.9)

10 (16.7)

0.37 (0.11, 1.26)

0.11

Hospital Readmission, n (%)

0 (0)

5 (8.3)

0.09 (0.0, 0.79)

0.10

Hypertensive Disorder complication, n (%)

4 (6.9)

7 (11.7)

0.56 (0.16, 2.03)

0.38

Any Postoperative Complication, n (%)

20 (34.5)

28 (46.7)

0.60 (0.29, 1.26)

0.17

Table 4. Survey Results Enhanced Recovery

Standard Recovery

Do you feel that you were properly educated about the recovery process before your cesarean?, n (%) Strongly Agree

26 (46.4)

18 (34.0)

Agree

30 (53.6)

35 (66.0)

Disagree

0 (0)

0 (0)

Strongly Disagree

0 (0)

0 (0)

0.18

Do you feel that the recovery process after your delivery met your expectations?, n (%) Strongly Disagree

0 (0)

0 (0)

Disagree

0 (0)

0 (3.8)

Agree

16 (28.6)

29 (54.7)

Strongly Agree

40 (71.4)

22 (41.5)

Do you feel that you were prevented from eating or drinking for too long prior to the procedure?, n (%) Strongly Agree

0.003

0.004 0 (0)

0 (0)

Agree

21 (37.5)

36 (67.9)

Disagree

32 (57.1)

16 (30.2)

3 (5.4)

1 (1.9)

Strongly Disagree Did you encounter any postopertive nausea or vomiting after your cesarean?, n (%) Yes No

P-value

0.68 5 (8.9)

6 (11.3)

51 (91.1)

47 (88.7)

Did you encounter any difficulty eating after your cesarean?, n (%)

1.00 Yes

3 (5.4)

2 (3.9)

No

53 (94.6)

50 (96.2)

Approximately, how soon after your cesarean were you able to begin drinking?, n (%) 0-30 min

0.0002 0 (0)

0 (0)

1 (1.8)

1 (1.9)

1h-3h

34 (60.7)

13 (24.5)

4h-6h

21 (37.5)

39 (73.6)

30-60 min

Approximately, how soon after your cesarean were you able to begin eating?, n (%) 0-30 min

0 (0)

0 (0)

30-60 min

0 (0)

0 (0)

1h-3h

6 (10.7)

7 (13.2)

4h-6h

50 (89.3)

46 (86.8)

Approximately how soon after your cesarean were you able to get out of bed?, n (%) 0-2h 2h-4h

0.69

0.01 0 (0)

0 (0)

1 (1.8)

0 (0)

4h-6h

21 (37.5)

9 (17.0)

6h+

34 (60.7)

44 (83.0)

Approximately, how soon after your cesarean were you able to resume your normal activities?, n (%) 0-2h

0 (0)

0 (0)

2h-4h

0 (0)

0 (0)

4h-6h

12 (21.4)

15 (28.3)

6h+

44 (78.6)

38 (71.7)

0.41

Did you encounter any difficulty urinating after your cesarean?, n (%)

0.61 Yes

1 (1.8)

2 (3.9)

No

54 (98.2)

50 (96.2)

Were you able to have skin-to-skin contact with your baby after your cesarean?, n (%) Strongly Agree Agree Disagree Strongly Disagree

0.72 3 (5.4)

1 (1.9)

51 (91.1)

50 (94.3)

2 (3.6)

1 (1.9)

0 (0)

1 (1.9)

Were you satisfied with your ability to bond with your baby after your cesarean?, n (%) Strongly Agree

11 (19.6)

7 (13.2)

Agree

45 (80.4)

45 (84.9)

Disagree

0 (0)

1 (1.9)

Strongly Disagree

0 (0)

0 (0)

Were you satisfied with your ability to breastfeed?, n (%) Strongly Agree

0.44

0.56 8 (14.8)

3 (7.5)

43 (79.6)

36 (90.0)

Disagree

1 (1.9)

1 (2.5)

Strongly Agree

2 (3.7)

0 (0)

Agree

How long after the birth of your baby did you continue to breastfeed?, n (%) Few hours

0 (0)

0 (0)

Few days

0 (0)

4 (7.6)

Few weeks

11 (19.6)

15 (28.3)

Few months

40 (71.4)

20 (37.7)

5 (8.9)

14 (26.4)

No breastfeeding Do you feel that your pain was well-controlled after your cesarean?, n (%) Strongly Agree Agree Disagree Strongly Disagree

0.001

0.52 4 (7.1)

1 (1.9)

51 (91.1)

50 (94.3)

1 (1.8)

2 (3.8)

0 (0)

0 (0)

Did you encounter any infections or complications with your incision after your cesarean?, n (%) Yes No

0.35 1 (1.8)

3 (5.7)

55 (98.2)

50 (94.3)

Did you encounter any urinary infections after your cesarean?, n (%)

NA Yes

0 (0)

0 (0)

No

56 (100)

53 (100)

Were you readmitted to the hospital for any reason after your cesarean?, n (%)

0.20 Yes

1 (1.8)

4 (7.6)

No

55 (98.2)

49 (92.5)

Did you experience postpartum depression?, n (%)

1.00 Yes

2 (3.6)

1 (1.9)

No

54 (96.4)

52 (98.1)

Do you feel that you were satisfied with the overall experience after your cesarean?, n (%) Strongly Agree

28 (50.0)

24 (45.3)

Agree

28 (50.0)

25 (47.2)

Disagree

0 (0)

4 (7.6)

Strongly Disagree

0 (0)

0 (0)

0.15